CVS Health (NYSE: CVS), the nation’s largest pharmacy innovation company, today (April 5, 2017) was recognized by Billion Dollar Roundtable, a top-level corporate advocacy organization that promotes supply-chain diversity excellence, for reaching its goal of spending over $1 billion with diverse suppliers.
“We are incredibly proud to be recognized by Billion Dollar Roundtable for our commitment to using diverse suppliers throughout our business,” said Eva Boratto, Executive Vice President, Chief Accounting Officer for CVS Health. “By tapping into this expanding supplier pool, we are able to build supply chain excellence, add distinctive goods and services to our business offerings and enhance our brand among customers.”
CVS Health joins the ranks as one of 26 major U.S.-based corporations that provide thought leadership and solutions-driven exploration of key issues in supplier diversity. Billion Dollar Roundtable member companies each spend $1 billion or more annually for a broad range of goods and services with certified diverse companies whose majority owners primarily are minorities and women.
This recognition is the latest in a series of third-party acknowledgments, including CVS Health being ranked #45 on Fortune’s Most Admired Companies in 2017, #3 on Fast Company’s 50 Most Innovative Companies in 2016 and among the World’s Most Valuable Brands by Forbes . The company also received awards recognizing its innovation, leadership, and workplace practices by CIO (100 Best Companies for IT Innovation), Corporate Responsibility Magazine (100 Best Corporate Citizens), Human Rights Campaign (Best Places to Work for LGBT Equality) and Disability Equality Index (Best Places to Work).